Mangalam Drugs receives Rs. 15 crore repeat export order
The receipt of this order further strengthens the company's position in the global pharmaceutical market
The receipt of this order further strengthens the company's position in the global pharmaceutical market
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
GV20 received an upfront payment and is eligible for additional milestone payments
GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030
The drug, intended for chronic weight management alongside diet and exercise, is now under the FDA’s new CNPV expedited review pathway
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
Clinical trials found that 77% of patients went into remission after receiving obe-cel
The clearance for TELLTALE positions Transmural Systems at the forefront of next-generation electrosurgical solutions for structural heart interventions
The fresh capital will propel Cordance into its first-in-human clinical trial
Subscribe To Our Newsletter & Stay Updated